Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.

NCT05182125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: AdC6-HIVgp140
BIOLOGICAL: AdC7-HIVgp140
BIOLOGICAL: CH505TF gp120
BIOLOGICAL: GLA-SE (glucopyranosyl lipid A - stable emulsion; [labeled as AP 10-201])
BIOLOGICAL: Placebo

Sponsor

HIV Vaccine Trials Network

Collaborators

[object Object]
[object Object]
[object Object]